However, given the possible link, a new update will advise patients with a history of Guillain-Barré syndrome to seek mRNA vaccines. CDC's Dr. Hannah Rosenblum, who presented during the Advisory Committee on Immunization Practices (ACIP) meeting Thursday, said "this assessment demonstrates that the benefits of COVID-19 vaccination far outweigh the potential risks." GUILLAIN-BARRÉ SYNDROME REPORTED IN FEW JOHNSON & JOHNSON VACCINE RECIPIENTS: WHAT IS THE RARE NERVE DISORDER? The news comes after the FDA on July 12 announced 100 preliminary reports of Guillain-Barré cases against a backdrop of about 12.5 million Johnson & Johnson doses administered. FDA WARNS ON POTENTIAL JOHNSON & JOHNSON COVID-19 VACCINE LINK TO RARE DISORDERGuillain-Barré syndrome (GBS) occurs when a person’s immune system and inflammation damage the nerves, spurring muscle weakness and in some severe cases, paralysis, according to the CDC.

Source: Fox News July 22, 2021 16:52 UTC